Intestinal Re-Transplantation.


Journal

Gastroenterology clinics of North America
ISSN: 1558-1942
Titre abrégé: Gastroenterol Clin North Am
Pays: United States
ID NLM: 8706257

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 28 7 2024
pubmed: 28 7 2024
entrez: 27 7 2024
Statut: ppublish

Résumé

The history of intestinal transplantation can be traced back to the turn of the twentieth century. Although advancements have been made, the intestine still presents a greater challenge to transplantation than does that of other solid organs, experiencing higher rates of graft rejection and lower long-term survival. Increasingly, intestinal re-transplantation (re-ITx) is seen as a viable option and is now the fourth most common indication for ITx. Changes to immunosuppression protocols, technical modifications, and infectious disease monitoring have contributed to improved outcomes. The authors review the literature on re-ITx in regard to the history, management considerations, and future directions.

Identifiants

pubmed: 39068006
pii: S0889-8553(24)00004-9
doi: 10.1016/j.gtc.2024.01.004
pii:
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-459

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Disclosure The authors declare that they have no relevant or material financial interests that relate to the research described in this paper.

Auteurs

Carolyn P Smullin (CP)

Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Robert S Venick (RS)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Elizabeth A Marcus (EA)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Suzanne V McDiarmid (SV)

Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Hasan Yersiz (H)

Division of Liver and Pancreas Transplantation, Department of Surgery, The Dumont UCLA Transplant Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Ronald W Busuttil (RW)

Division of Liver and Pancreas Transplantation, Department of Surgery, The Dumont UCLA Transplant Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Douglas G Farmer (DG)

Division of Liver and Pancreas Transplantation, Department of Surgery, The Dumont UCLA Transplant Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: dgfarmer@mednet.ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH